Regulation of cardiac development by receptor tyrosine kinases

Trends in Cardiovascular Medicine

Volumn 8, Issue 1, 1998, Pages 34-40

  Tessarollo, Lino ^a   Hempstead, Barbara L ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; SCATTER FACTOR; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

CELL POPULATION; EMBRYO DEVELOPMENT; ENDOCARDIUM; ENZYME ACTIVITY; GENE TARGETING; GROWTH REGULATION; HEART DEVELOPMENT; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE CELL; HUMAN; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031909815     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00119-9     Document Type: Review

References (59)

1. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature. 376:1995;768-771.
2. Brannan CI, Perkins AS, Vogel KSet al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8:1994;1019-1029.
3. Bronner-Fraser M Neural crest cell migration in the developing embryo. FASEB J. 8:1994;699-706.
4. Carmeliet P, Ferreira V, Breler Get al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
5. Chao MV, Hempstead BL p75 and Trk: a two-receptor system. Trends Neurosci. 18:1995;321-326.
6. Choy M, Oltjen SL, Otani YS, Armstrong MT, Armstrong PB Fibroblast growth factor-2 stimulates embryonic cardiac mesenchymal cell proliferation. Dev Dyn. 206:1996;193-200.
7. Clark EB: 1990. Growth, morphogenesis and function: the dynamic of cardiac development. In Moller JH, Neal WA, eds. Fetal, Neonatal and Infant Cardiac Disease. Norwalk, CT, Appleton and Lange, pp 3-33.
8. Davis S, Aldrich TH, Jones PFet al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169.
9. Donovan MJ, Miranda RC, Kraemer Ret al. Neurotrophins and neurotrophin receptors in vascular smooth muscle cells: regulation of expression in response to injury. Am J Pathol. 147:1995;309-324.
10. Donovan MJ, Hahn R, Tessarollo L, Hempstead BL Identification of an essential nonneuronal function of neurotrophin-3 in mammalian cardiac development. Nat Genet. 14:1996;210-213.
11. Dumont D, Fong G, Puri M, Gradwohl G, Alitalo K, Breitman M Vascularization of the mouse embryo: a study of the flk-1, tek, tie and vascular epithelial growth factor expression during development. Dev Dyn. 203:1995;80-92.
12. Fantl WJ, Johnson DE, Williams LT Signaling by receptor tyrosine kinases. Annu Rev Biochem. 62:1993;453-481.
13. Feldman B, Poueymirou W, Papaioannou VE, SeChaira TM, Goldfarb M Requirement for FGF-4 for postimplantation mouse development. Science. 267:1995;246-249.
14. Ferrara N, Carver-Moore K, Chen Het al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
15. Fong GH, Rossant J, Gertenstein M, Breitman ML Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
16. Gassmann M, Casagranda F, Orioli Det al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature. 378:1995;390-394.
17. Heldin C-H Dimerization of cell surface receptors in signal transduction. Cell. 80:1995;213-223.
18. Henion PD, Garner AS, Large TH, Weston JA Trk-mediated NT-3 signaling is required for the early development of a subpopulation of neurogenic neural crest cells. Dev Biol. 172:1995;602-613.
19. Hermann JL, Menter DG, Hamada J, Marchetti D, Nakajima M, Nicolson GL Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell. 4:1993;1205-1216.
20. Hiltunen JO, Arumäe U, Moshnyakov M, Saarma M Expression of mRNAs for neurotrophins and their receptors in developing rat heart. Circ Res. 79:1996;930-939.
21. Jaks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weimberg RA Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet. 7:1994;353-361.
22. Kirby ML Cellular and molecular contributions of the cardiac neural crest to cardiovascular development. Trends Cardiovasc Med. 3:1993;18-23.
23. Kirby ML, Kumiski DH, Myers T, Cerjan C, Mishima N Backtransplantation of chick cardiac neural crest cells cultured in LIF rescues heart development. Dev Dyn. 198:1993;296-311.
24. Koch AE, Halloran MM, Hosaka Set al. Hepatocyte growth factor: a cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum. 39:1996;1566-1575.
25. Korhonen L, Polvi A, Partanen J, Alitalo K The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene. 9:1994;395-403.
26. Kramer R, Bucay N, Kane DJ, Martin LE, Tarpley JE, Theill LE Neuregulins with an IG-like domain are essential for mouse myocardial and neuronal development. Proc Natl Acad Sci USA. 93:1996;4833-4838.
27. Kurihara Y, Kurihara H, Oda Het al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest. 96:1995;293-300.
28. Lee K-F, Simon H, Chen H, Bates B, Hung M-C, Hauser C Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature. 378:1995;394-398.
29. Lewin GR, Barde Y-A Physiology of neurotrophins. Annu Rev Neurosci. 19:1996;289-317.
30. Maisonpierre PC, Suri C, Jones PFet al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
31. Majesky MA A little VEGF goes a long way. Circulation. 94:1996;3062-3064.
32. Marchionni MA Cell-cell signalling, new tack on neuregulin. Nature. 378:1995;334-335.
33. Mason I The ins and outs of fibroblast growth factors. Cell. 78:1994;547-552.
34. Meyer D, Birchmeier C Multiple essential functions of neuregulin in development. Nature. 378:1995;334-335.
35. Mima T, Ueno H, Fischman DA, Williams LT, Mikawa T Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci USA. 92:1995;467-471.
36. Nagasawa T, Hirota S, Tachibana Ket al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:1996;635-638.
37. Noden DM Origins and patterning of avian outflow tract endocardium. Development. 111:1991;867-876.
38. Olson EN, Srivastava D Molecular pathways controlling heart development. Science. 272:1996;671-676.
39. Orr-Urtreger A, Givol D, Yayon A, Yarden Y, Lonai P Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development. 113:1991;1419-1434.
40. Patstone G, Pasquale EB, Maher PA Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo. Dev Biol. 155:1993;107-123.
41. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14:1995;5884-5891.
42. Rappolee DA, Iyer A, Patel Y Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis. Circ Res. 78:1996;1028-1036.
43. Rosen E, Nigam S, Goldberg I Scater factor and c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol. 127:1994;1783-1787.
44. Ruoslahti E, Yamaguchy Y Proteoglycans as modulators of growth factor activities. Cell. 63:1991;867-869.
45. Sato TN, Tozawa Y, Deutsch Uet al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:1995;70-74.
46. Scarisbrick IA, Jones EG, Isackson PJ Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. J Neurosci. 13:1993;875-893.
47. Schmith C, Bladt F, Goedecke Set al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 373:1995;699-702.
48. Shalaby R, Rossant J, Yamaguchi TPet al. Failure of blood island formation and vasculogenesis in Flk-1 deficient mice. Nature. 376:1995;62-66.
49. Sugi Y, Sasse J, Lough J Inhibition of precardiac mesoderm cell proliferation by antisense oligonucleotide complementary to fibroblast growth factor-2. Dev Biol. 157:1993;28-37.
50. Sugi Y, Sasse J, Barron M, Lough J Developmental expression of fibroblast growth factor receptor-1 (cek-1; flg) during heart development. Dev Dyn. 202:1995;115-125.
51. Suri C, Jones PF, Patan Set al. Requisite role of Angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
52. Tessarollo L, Tsoulfas P, Donovan MJ, et al. Targeted deletion of all isoforms of the trk C gene suggests the use of alternate receptors by its ligand, neurotrophin-3 in neuronal development and implicates trk C in normal cardiogenesis. Proc Natl Acad Sci USA (in press).
53. Tessarollo L, Tsoulfas P, Martin-Zanca Det al. trkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues. Development. 118:1993;463-475.
54. Uehara Y, Minowa O, Mori Cet al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 373:1995;702-705.
55. Wang DZM, Hammond VE, Abud HEet al. Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development. Genes Dev. 11:1997;309-320.
56. Williams R, Backstrom A, Ebendal T, Hallbook F Molecular cloning and cellular localization of trkC in the chicken embryo. Brain Res Dev Brain Res. 75:1993;235-252.
57. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML flk-1, An flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development. 118:1993;489-498.
58. Yang R, Thomas GR, Bunting Set al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol. 27:1996;838-844.
59. Yoshida K, Taga T, Saito Met al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA. 93:1996;407-411.